Methoxy poly(ethylene glycol) – Low molecular weight linear polyethylenimine-derived copolymers enable polyplex shielding
- 1 May 2008
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 69 (1) , 134-148
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Polyethylenimine-based non-viral gene delivery systemsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Gene delivery with low molecular weight linear polyethyleniminesThe Journal of Gene Medicine, 2005
- Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexesJournal of Controlled Release, 2003
- Prospects for cationic polymers in gene and oligonucleotide therapy against cancerAdvanced Drug Delivery Reviews, 2002
- Polyethylenimine-graft-Poly(ethylene glycol) Copolymers: Influence of Copolymer Block Structure on DNA Complexation and Biological Activities as Gene Delivery SystemBioconjugate Chemistry, 2002
- Intranasal gene delivery with a polyethylenimine–PEG conjugateJournal of Controlled Release, 2002
- Biodegradable poly(ethylenimine) for plasmid DNA deliveryJournal of Controlled Release, 2002
- Non-viral gene delivery systemsCurrent Opinion in Biotechnology, 2002
- Sterically stabilized polyplex: ligand-mediated activityJournal of Controlled Release, 2001
- PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene deliveryGene Therapy, 1999